One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
Leveraging a variety of artificial intelligence (AI) capabilities, the newly launched Voluson Signature 20 and 18 ultrasound devices may significantly enhance efficiency of common ultrasound exams for women.
GE HealthCare, the manufacturer of the Voluson Signature 20 and 18 ultrasound devices, said key efficiencies include:
• a 48 percent time reduction for performing fetal heart assessments due to a fetalHS feature, which provide stepwise AI guidance to identify normal fetal heart anatomy;
The SonoLyst feature, a suite of automated AI tools available with the newly launched Voluson Signature 20 and 18 ultrasound devices, reportedly facilitates a 40 percent time reduction for performing second trimester exams as per standards from the International Society of Ultrasound in Obstretics and Gynecology (ISUOG). (Image courtesy of GE HealthCare.)
• a 40 percent time reduction for performing second trimester exams as per standards from the International Society of Ultrasound in Obstretics and Gynecology (ISUOG) due to the SonoLyst feature, a suite of automated AI tools; and
• a 76 percent keystroke reduction with the automated plane alignment and measurements of the SonoPelvicFloor feature.
"We've seen huge advancements in ultrasound technology, including the use of AI, resulting in a new era of ultrasound scanning. The new Voluson Signature series features innovative tools clinicians can rely on, and the automated functions help reduce work stress and improve workflows," noted Ben Csapo, M.D., a maternal fetal medicine specialist in Graz, Austria.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Ultrasound-Guided Thermal Ablation Shows Low Recurrence of Thyroid Carcinoma at Five Years
June 16th 2025In a meta-analysis involving over 2,200 patients with T1NoMo papillary thyroid carcinoma, researchers noted 2 percent recurrence and no cases of lymph node metastasis five years after ultrasound-guided thermal ablation.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.